Credit Suisse Downgrades Infinity Pharmaceutical (INFI) to Neutral

December 12, 2013 6:41 AM EST Send to a Friend
Get Alerts INFI Hot Sheet
Price: $16.65 +2.27%

Rating Summary:
    11 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 3 | Down: 9 | New: 9
Trade INFI Now!
Join SI Premium – FREE
Credit Suisse downgraded Infinity Pharmaceutical (NASDAQ: INFI) from Outperform to Neutral with a price target of $20.00 (unchanged).

For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.

Shares of Infinity Pharmaceutical closed at $13.31 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Credit Suisse

Add Your Comment